Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, continues to pose significant health challenges globally. Despite advancements in diagnostic technology and therapeutics, the disease remains a major cause of morbidity and mortality in developing countries. This article provides an updated approach to the diagnosis and management of enteric fever, targeting healthcare professionals.
Early diagnosis of enteric fever is crucial for effective management. Culturing of blood and bone marrow remains the gold standard for diagnosis. However, these methods are time-consuming and may yield false negatives. Recent advancements include molecular methods such as PCR and serological tests like Typhidot and Tubex. These rapid diagnostic tests, although not as sensitive as culture methods, provide quicker results and are especially useful in resource-limited settings.
Antibiotic therapy is the cornerstone of enteric fever management. Historically, chloramphenicol, ampicillin, and cotrimoxazole were the drugs of choice. However, due to increasing drug resistance, fluoroquinolones became the preferred treatment. Unfortunately, resistance to these drugs is also emerging. Third-generation cephalosporins and azithromycin are now the recommended first-line treatments. It is essential to monitor local antimicrobial resistance patterns and adjust treatment accordingly.
Vaccination can play a significant role in preventing enteric fever. Two vaccines are currently available: the oral live attenuated Ty21a vaccine and the injectable Vi polysaccharide vaccine. Both vaccines have demonstrated moderate efficacy and are recommended for travelers to endemic areas and high-risk populations. Hand hygiene, safe food practices, and clean water supply remain critical for prevention.
Enteric fever continues to be a significant health burden, particularly in resource-poor settings. Early diagnosis and appropriate antibiotic treatment are crucial for effective disease management. In the face of growing antimicrobial resistance, the importance of vaccination and preventive measures cannot be overstated. Healthcare professionals must stay updated with the latest diagnostic and therapeutic advancements to combat this persistent disease effectively.
1.
Regular physical activity before cancer diagnosis may lower progression and death risks
2.
Medication Self-Injection Embraced by Breast Cancer Patients
3.
Financial hardship for cancer survivors due to high-cost immunotherapies, especially for blood cancer patients
4.
FDA Advisors Split on Regimens for Breast, Prostate Cancers
5.
ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs
1.
RDW-CV vs. MCV: Knowing the Difference Can Help You Better Understand Your Health
2.
Clinical Pathways in Hematology in Clinical Decision-Making
3.
Immune Surveillance Screening for Early Cancer Risk Detection
4.
Unlocking the Mysteries of Lymphoblastic Lymphoma: A Journey Into the Unknown
5.
AI-Driven Digital Pathology in Oncology: From Histology Images to Predictive Treatment Biomarkers
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
How Advances in Cancer Research Are Improving Treatment Options
2.
Navigating the Complexities of Ph Negative ALL - Part II
3.
Signs and Symptoms of Leukemia
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Virtual Case Study on Elephantiasis of Lower Limb- An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation